NORDICCELL ApS: Financial statements 2017
CVR: 27293972
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
NORDICCELL ApS (CVR 27293972) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 7,136,216 and a net result of DKK 2,616,409 compared with DKK 2,018,999 the year before. That is an increase of 27.9% compared with the year before. Equity in the 2017 report amounted to DKK 3,960,181. The solvency ratio was 54.6%. The company had 9 employees in the financial year.
- Gross Profit
- DKK 7,136,216
- Profit/Loss
- DKK 2,616,409
- Equity
- DKK 3,960,181
- Total Assets
- DKK 7,256,523
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 7.1 mio. | 2.6 mio. | 4 mio. | 9 |
| 2016 | - | 5.6 mio. | 2 mio. | 1.3 mio. | 8 |
| 2015 | - | 4.8 mio. | 1.5 mio. | 1.3 mio. | 7 |
| 2014 | - | 3.8 mio. | 1.2 mio. | 1.3 mio. | 6 |
| 2013 | - | 2.7 mio. | 546 t. | 1.1 mio. | - |
Official annual report
Keep an eye on NORDICCELL ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout NORDICCELL ApS
NORDICCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anders Bek-Pedersen. The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 11 employees (2018). In 2025, the company reported a gross profit of DKK 8,909,296 and a net result of DKK 1,701,475 compared with DKK 1,272,903 the year before. Equity in the 2025 report amounted to DKK 4,976,358.